Screener
Protagonist Therapeutics PTGX Income Taxes Payable
Income Taxes Payable at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Accounts payable | (1,897) | 1,612 |
| Accrued expenses and other payables | (6,602) | (8,378) |
| Deferred revenue | 109 | (10,504) |
| Income taxes payable | — | (2,689) |
| Operating lease liability | (1,107) | 104 |
| Other non-current asset | (832) | — |
| Net cash provided by operating activities | 170,109 | 96,583 |
| Cash Flows from Investing Activities |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Protagonist Therapeutics's income taxes payable?
- Protagonist Therapeutics (PTGX) reported income taxes payable of -$1.89M in Q2 2025.
- How has Protagonist Therapeutics's income taxes payable changed year-over-year?
- Protagonist Therapeutics's income taxes payable decreased by 171.3% year-over-year, from $2.65M to -$1.89M.
- What does income taxes payable mean?
- Current income taxes owed to federal, state, and local tax authorities for the current and prior periods.
Ask your AI about Protagonist Therapeutics's income taxes payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude